Medicine guide

Cuvitru 200 mg/ml

As listed in the register: Cuvitru 200 mg/ml, Injektionslösung

200 mg/ml ·

  • Prescription only
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Takeda Pharma AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Substitutionstherapie bei primären Immunmangelkrankheiten, Substitutionstherapie bei multiplem Myelom, chronisch-lymphatischer Leukämie oder nach allogener hämatopoetischer Stammzellentransplantation mit sekundärer Hypogammaglobulinämie

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byTakeda Pharma AG
Active substanceImmunoglobulinum humanum normale
Used inAntibiotics, antivirals and antifungals taken into the body
Strength200 mg/ml
ClassificationJ06BA01 · Antibiotics, antivirals and antifungals taken into the body
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerCuvitru 200 mg/ml, Injektionslösung
Packs5 ml · 10 ml · 20 ml · 40 ml · 50 ml
Zulassungsnummer65992
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.